Defendant appealed from a judgment of conviction, arguing the trial court should have granted his motion to dismiss the indictment because the substance he possessed alpha-PVP, also known as "flakka", was not listed as a Schedule I drug under New Jersey law. When the federal government schedules a substance, N.J.S.A. 24:21-3(c) gives the Director of Consumer Affairs in the Department of Law and Public Safety thirty days to do one of two things: (1) control the substance consistent with the federal government's scheduling, or (2) file an objection in the New Jersey Register. Absent is a requirement that the Director give notice when he or she intends to control the substance as directed by federal law. Thus, if the Director fails to file an objection to the federal government's scheduling within thirty days, as was the case with alpha-PVP, the Director must control the substance consonant with federal law. Thus alpha-PVP was automatically included in Schedule I because the Director did not object to the federal government's designation.